| |
| |
|
| Insider
Information: |
Aldrich Richard |
| Relationship: |
Director |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
10 |
|
| Direct
Shares |
444,838 |
|
|
Indirect Shares
|
12,959,539 |
|
|
| Direct
Value |
$1,394,222 |
|
|
|
Indirect Value
|
$84,759,662 |
|
|
| Total
Shares |
13,404,377 |
|
|
| Total
Value |
$86,153,884 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 81.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Altus Pharmaceuticals Inc. |
ALTUQ |
Director |
2006-01-25 |
30,527 |
|
0 |
Premium* |
|
|
Lipid Sciences Inc |
LIPD |
10% Owner |
2006-12-21 |
0 |
2006-12-21 |
3,662,662 |
Premium* |
|
|
Sequenom Inc |
SQNM |
10% Owner |
2008-06-06 |
0 |
2008-06-25 |
5,853,697 |
Premium* |
|
|
Aradigm Corp |
ARDM |
10% Owner |
2008-10-29 |
0 |
2008-10-29 |
1,081,410 |
Premium* |
|
|
Biospecifics Technologies Corp |
BSTC |
10% Owner |
2008-10-30 |
0 |
2008-11-14 |
697,309 |
Premium* |
|
|
Verastem, Inc. |
VSTM |
Director |
2014-05-20 |
408,142 |
2014-05-20 |
299,294 |
Premium* |
|
|
Tempest Therapeutics, Inc |
TPST |
Director |
2018-12-07 |
6,169 |
2018-12-07 |
130,683 |
Premium* |
|
|
PTC Therapeutics, Inc. |
PTCT |
Director |
2015-06-08 |
0 |
2013-06-25 |
300,000 |
Premium* |
|
|
Concert Pharmaceuticals, Inc. |
CNCE |
Director |
2023-03-06 |
0 |
2023-03-06 |
0 |
Premium* |
|
|
Kalvista Pharmaceuticals Inc |
KALV |
Director |
2016-11-21 |
0 |
2017-10-12 |
934,484 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
141 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALTUQ |
Altus Pharmaceuticals Inc... |
officerTitle |
– • – |
2006-01-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
30,527 |
|
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2017-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
7,482 |
34,263 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2017-12-29 |
4 |
A |
$0.00 |
$0 |
D/D |
7,589 |
41,852 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Director |
– • – |
2018-01-25 |
4 |
AS |
$20.22 |
$163,302 |
I/I |
(8,054) |
44,351 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Director |
– • – |
2018-01-24 |
4 |
AS |
$19.83 |
$198,300 |
I/I |
(10,000) |
47,405 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Director |
– • – |
2018-01-23 |
4 |
AS |
$19.67 |
$196,750 |
I/I |
(10,000) |
52,405 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2018-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
13,101 |
54,953 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Director |
– • – |
2018-01-22 |
4 |
AS |
$19.54 |
$195,450 |
I/I |
(10,000) |
57,405 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Director |
– • • |
2014-02-19 |
4 |
A |
$0.00 |
$0 |
I/I |
61,946 |
61,946 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Director |
– • – |
2018-01-19 |
4 |
AS |
$19.65 |
$196,550 |
I/I |
(10,000) |
62,405 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2018-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
11,709 |
66,662 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Director |
– • – |
2018-01-18 |
4 |
AS |
$19.36 |
$193,950 |
I/I |
(10,000) |
67,405 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Director |
– • – |
2018-01-17 |
4 |
AS |
$18.95 |
$189,900 |
I/I |
(10,000) |
72,405 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Director |
– • – |
2018-01-16 |
4 |
AS |
$19.26 |
$192,650 |
I/I |
(10,000) |
77,405 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2018-09-28 |
4 |
A |
$0.00 |
$0 |
D/D |
14,558 |
81,220 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Director |
– • – |
2014-10-16 |
4 |
GA |
$0.00 |
$0 |
I/I |
82,405 |
82,405 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Director |
– • – |
2015-08-26 |
4 |
GA |
$0.00 |
$0 |
I/I |
82,405 |
82,405 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Director |
– • • |
2014-02-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
102,417 |
|
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2016-03-11 |
4 |
B |
$7.50 |
$995,490 |
I/I |
132,732 |
132,732 |
2.1 |
- |
|
| VSTM |
Verastem, Inc. |
Director |
– • • |
2012-01-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
135,714 |
|
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2016-12-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
645,842 |
161,865 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2016-03-14 |
4 |
B |
$8.05 |
$241,602 |
I/I |
30,000 |
162,732 |
2.1 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • • |
2012-06-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
175,481 |
|
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2015-06-30 |
4 |
GA |
$0.00 |
$0 |
I/I |
175,481 |
175,481 |
0 |
- |
|
| TPST |
Tempest Therapeutics, Inc |
Director |
– • – |
2016-03-15 |
4 |
B |
$7.80 |
$237,802 |
I/I |
29,500 |
192,232 |
2.1 |
- |
|
141 Records found
|
|
Page 3 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
